Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human KAT2B Antibodies:
anti-Mouse (Murine) KAT2B Antibodies:
anti-Rat (Rattus) KAT2B Antibodies:
Go to our pre-filtered search.
Human Polyclonal KAT2B Primary Antibody for EIA, WB - ABIN954022
Perez, Knights, Sahu, Catania, Kolukula, Stoler, Graessmann, Ogryzko, Pishvaian, Albanese, Avantaggiati: Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway. in Journal of cellular physiology 2010
Show all 3 references for ABIN954022
Human Polyclonal KAT2B Primary Antibody for EIA, WB - ABIN954021
Mooney, Goel, DAssoro, Salisbury, Janknecht: Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. in The Journal of biological chemistry 2010
Show all 3 references for ABIN954021
Human Polyclonal KAT2B Primary Antibody for WB - ABIN656013
Xiong, Svingen, Sarmento, Smyrk, Dave, Khanna, Lomberk, Urrutia, Faubion: Differential coupling of KLF10 to Sin3-HDAC and PCAF regulates the inducibility of the FOXP3 gene. in American journal of physiology. Regulatory, integrative and comparative physiology 2014
Cow (Bovine) Polyclonal KAT2B Primary Antibody for WB - ABIN2787454
Zeng, Zhang, Gerona-Navarro, Moshkina, Zhou: Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. in Structure (London, England : 1993) 2008
Cow (Bovine) Polyclonal KAT2B Primary Antibody for WB - ABIN2779660
Chu, Tran, Ku, Crowe: Regulation of ERK1 gene expression by coactivator proteins. in The Biochemical journal 2005
The studies identify a P/CAF-PAX3 (show PAX3 Antibodies)-FOXO1 (show FOXO1 Antibodies) signalling node that promotes oncogenesis and may contribute to MyoD (show MYOD1 Antibodies) dysfunction in Alveolar rhabdomyosarcoma (ARMS).
results strongly support our hypothesis that PCAF is induced and activated by ATRA, and the subsequent acetylation of PCAF substrates promotes granulocytic differentiation in leukemia cells
Our findings demonstrated a novel epigenetic mechanism of IL-10 (show IL10 Antibodies) dysregulation in inflammatory bowel disease. Down-regulation of KAT2B may disrupt the innate and adaptive inflammatory responses due to the suppression of this crucial anti-inflammatory cytokine.
Acetyltransferase p300/CBP-associated factor (PCAF) interacts with and acetylates HOXB9 (show HOXB9 Antibodies) both in vivo and in vitro.
Results suggest that increase in nuclear expression of p300 (show EP300 Antibodies), as well as the presence of cytoplasmic but loss of nuclear expression of p300/CBP-associated factor (PCAF), could play an important role in the development and progression of cutaneous squamous cell carcinomas (SCC (show CYP11A1 Antibodies)).
Loss of p300 (show EP300 Antibodies) reduced repair of mismatches in DNA mismatch repair-deficient cells, but did not have evident effects on Base Excision Repair (BER) mechanisms, including the long patch BER pathway.
Kat2b is a crucial transcriptional regulator for adaptive betaeta cell function during metabolic stress by controlling Unfolded Protein Response and represents a promising target for type 2 diabetes prevention and treatment.
data define an essential motif cNM (show MTM1 Antibodies) in N-terminal E1A (show BCKDHA Antibodies) as an acetyl-CoA (show LPCAT2 Antibodies) entry blocker that directly associates with the entrance of acetyl-CoA (show LPCAT2 Antibodies) binding pocket to block the HAT (show MGEA5 Antibodies) domain access to its cofactor
PCAF protein and mRNA were not expressed in normal brain, but were expressed in pediatric astrocytoma in levels decreasing with tumor grade.
Notch (show NOTCH1 Antibodies) signaling was altered in almost half of the clear-cell renal cell carcinoma (show MOK Antibodies) patients and copy number variances in MAML1 (show MAML1 Antibodies) and KAT2B were predominant changes.
This study demonstrated that pcaf increase in skeletal muscle in muscle atrophy.
Treatment with a pan (show SUPT6H Antibodies)-acetylase inhibitor, anacardic acid, reduced the binding affinity of p300 (show NOTCH1 Antibodies) and PCAF to the NKX2.5 (show NKX2-5 Antibodies), beta-MHC (show MYH7 Antibodies), Cx43 (show GJA1 Antibodies) promoters and attenuated H3K9 hyperacetylation.
Gcn5 (show KAT2A Antibodies) and PCAF repress IFN-beta (show IFNB1 Antibodies) production in an enzymatic activity-independent and non-transcriptional manner: by inhibiting the innate immune signaling kinase TBK1 (show TBK1 Antibodies) in the cytoplasm.
PCAF acetylates two lysine residues K328 and K450 in PGC-1alpha (show PPARGC1A Antibodies). PCAF in the obese mouse liver greatly represses gluconeogenic enzyme activation and glucose production and improves glucose homeostasis and insulin (show INS Antibodies) sensitivity.
Study reveals that Gcn5 (show KAT2A Antibodies)/PCAF facilitate adipogenesis through regulation of PPARgamma (show PPARG Antibodies) expression and regulate brown adipogenesis by influencing Prdm16 (show PRDM16 Antibodies) expression.
KLF10 (show KLF10 Antibodies), functions as a toggle to integrate antagonistic signals regulating FOXP3 (show FOXP3 Antibodies) via Sin3-HDAC (show HDAC3 Antibodies)/PCAF pathway and, thus, immune activation.
PCAF is necessary for axonal regeneration and also promotes regeneration after spinal cord injury.
These data unveil a p53 (show TP53 Antibodies)/PCAF/Gli1 (show GLI1 Antibodies) circuitry centered on PCAF that limits Gli1 (show GLI1 Antibodies)-enhanced mitogenic and prosurvival response.
PCAF is an important regulator for promoting osteoblast differentiation via acetylation modification of Runx2 (show RUNX2 Antibodies).
CSB (show ERCC6 Antibodies) and PCAF play cooperative roles to establish the active state of rRNA genes by histone acetylation
CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation.
, histone acetyltransferase KAT2B
, CREBBP-associated factor
, histone acetylase PCAF
, histone acetyltransferase PCAF
, lysine acetyltransferase 2B
, K(lysine) acetyltransferase 2B